Detalhe da pesquisa
1.
Current treatment strategies for EGFR-mutated non-small cell lung cancer: from first line to beyond osimertinib resistance.
Jpn J Clin Oncol
; 53(7): 547-561, 2023 Jun 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-37279591
2.
Initial Therapeutic Approach with Pembrolizumab in Synchronous Multiple Cancers, Including Non-Small Cell Lung Cancer, Highly Positive for Programmed Death-Ligand 1 Expression.
Chemotherapy
; 68(3): 160-167, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36577398
3.
Clinical Analysis of Extrapulmonary Neuroendocrine Carcinoma: A Retrospective and Single Institution Experience.
Chemotherapy
; 68(2): 87-94, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36327945
4.
Multi-institutional survey of antiemetic therapy in lung cancer patients treated with carboplatin in Hokushin region.
BMC Pulm Med
; 23(1): 228, 2023 Jun 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37365528
5.
Epidemiological and therapeutic profiles of lung cancer patients in the Hokushin Region Japan: a retrospective hospital administrative database study.
BMC Pulm Med
; 23(1): 322, 2023 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37658334
6.
Factors Affecting Nivolumab Therapy Outcome in Patients with Head and Neck Cancer: A Single-Center Analysis.
Oncology
; 100(4): 203-211, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35042219
7.
Evaluation of hepatic CYP3A enzyme activity using endogenous markers in lung cancer patients treated with cisplatin, dexamethasone, and aprepitant.
Eur J Clin Pharmacol
; 78(4): 613-621, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35039908
8.
Epidemiology of neuroendocrine neoplasmas in Japan: based on analysis of hospital-based cancer registry data, 2009â -â 2015.
BMC Endocr Disord
; 22(1): 105, 2022 Apr 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-35443668
9.
Prognostic impact of peripheral blood neutrophil to lymphocyte ratio in advanced-stage pulmonary large cell neuroendocrine carcinoma and its association with the immune-related tumour microenvironment.
Br J Cancer
; 124(5): 925-932, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33250511
10.
A Phase 1 study of gefitinib combined with durvalumab in EGFR TKI-naive patients with EGFR mutation-positive locally advanced/metastatic non-small-cell lung cancer.
Br J Cancer
; 124(2): 383-390, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33012782
11.
Five-year safety and efficacy data from a phase Ib study of nivolumab and chemotherapy in advanced non-small-cell lung cancer.
Cancer Sci
; 111(6): 1933-1942, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32277531
12.
Association of immune-related pneumonitis with the presence of preexisting interstitial lung disease in patients with non-small lung cancer receiving anti-programmed cell death 1 antibody.
Cancer Immunol Immunother
; 69(1): 15-22, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31745589
13.
Predictive value of serum VEGF levels for elderly patients or for patients with poor performance status receiving anti-PD-1 antibody therapy for advanced non-small-cell lung cancer.
Cancer Immunol Immunother
; 69(7): 1229-1236, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-32152703
14.
[Mediastinal Growing Teratoma Syndrome during Chemotherapy, Presenting as a Huge and Inoperable Tumor].
Gan To Kagaku Ryoho
; 47(10): 1497-1500, 2020 Oct.
Artigo
em Japonês
| MEDLINE | ID: mdl-33130749
15.
Individual optimal dose of amrubicin to prevent severe neutropenia in Japanese patients with lung cancer.
Cancer Sci
; 110(11): 3573-3583, 2019 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-31505087
16.
Modified Glasgow Prognostic Score as a Prognostic Factor in Patients with Extensive Disease-Small-Cell Lung Cancer: A Retrospective Study in a Single Institute.
Chemotherapy
; 64(3): 129-137, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31622969
17.
Effect of sequential chemoradiotherapy in patients with limited-disease small-cell lung cancer who were ineligible for concurrent therapy: a retrospective study at two institutions.
Jpn J Clin Oncol
; 48(1): 82-88, 2018 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29136177
18.
Efficacy and safety of osimertinib in a Japanese compassionate use program.
Jpn J Clin Oncol
; 47(7): 625-629, 2017 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28419328
19.
Pharmacokinetic profiles of significant adverse events with crizotinib in Japanese patients with ABCB1 polymorphism.
Cancer Sci
; 107(8): 1117-23, 2016 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-27270784
20.
Sensitive cytometry based system for enumeration, capture and analysis of gene mutations of circulating tumor cells.
Cancer Sci
; 107(3): 307-14, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26708016